Global Phenotypic Drug Discovery Market Insights, Forecast to 2029
This report presents an overview of global market for Phenotypic Drug Discovery market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Phenotypic Drug Discovery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Phenotypic Drug Discovery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Phenotypic Drug Discovery revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Phenotypic Drug Discovery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Phenotypic Drug Discovery revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Eurofins Discovery, Sygnature Discovery, PsychoGenics, siTOOLs Biotech, PhoreMost, Charles River, MaxWell and Arctoris, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Phenotypic Drug Discovery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Phenotypic Drug Discovery companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Phenotypic Drug Discovery revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Phenotypic Drug Discovery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Phenotypic Drug Discovery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Phenotypic Drug Discovery revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Phenotypic Drug Discovery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Phenotypic Drug Discovery revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Eurofins Discovery, Sygnature Discovery, PsychoGenics, siTOOLs Biotech, PhoreMost, Charles River, MaxWell and Arctoris, etc.
By Company
- Eurofins Discovery
- Sygnature Discovery
- PsychoGenics
- siTOOLs Biotech
- PhoreMost
- Charles River
- MaxWell
- Arctoris
- Platform
- Service
- Cancer
- Viral Infection
- Genetic Disease
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Phenotypic Drug Discovery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Phenotypic Drug Discovery companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Phenotypic Drug Discovery revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phenotypic Drug Discovery Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Platform
1.2.3 Service
1.3 Market by Application
1.3.1 Global Phenotypic Drug Discovery Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Viral Infection
1.3.4 Genetic Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Phenotypic Drug Discovery Market Perspective (2018-2029)
2.2 Global Phenotypic Drug Discovery Growth Trends by Region
2.2.1 Phenotypic Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Phenotypic Drug Discovery Historic Market Size by Region (2018-2023)
2.2.3 Phenotypic Drug Discovery Forecasted Market Size by Region (2024-2029)
2.3 Phenotypic Drug Discovery Market Dynamics
2.3.1 Phenotypic Drug Discovery Industry Trends
2.3.2 Phenotypic Drug Discovery Market Drivers
2.3.3 Phenotypic Drug Discovery Market Challenges
2.3.4 Phenotypic Drug Discovery Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Phenotypic Drug Discovery by Players
3.1.1 Global Phenotypic Drug Discovery Revenue by Players (2018-2023)
3.1.2 Global Phenotypic Drug Discovery Revenue Market Share by Players (2018-2023)
3.2 Global Phenotypic Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Phenotypic Drug Discovery, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Phenotypic Drug Discovery Market Concentration Ratio
3.4.1 Global Phenotypic Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phenotypic Drug Discovery Revenue in 2022
3.5 Global Key Players of Phenotypic Drug Discovery Head office and Area Served
3.6 Global Key Players of Phenotypic Drug Discovery, Product and Application
3.7 Global Key Players of Phenotypic Drug Discovery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 PHENOTYPIC DRUG DISCOVERY BREAKDOWN DATA BY TYPE
4.1 Global Phenotypic Drug Discovery Historic Market Size by Type (2018-2023)
4.2 Global Phenotypic Drug Discovery Forecasted Market Size by Type (2024-2029)
5 PHENOTYPIC DRUG DISCOVERY BREAKDOWN DATA BY APPLICATION
5.1 Global Phenotypic Drug Discovery Historic Market Size by Application (2018-2023)
5.2 Global Phenotypic Drug Discovery Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Phenotypic Drug Discovery Market Size (2018-2029)
6.2 North America Phenotypic Drug Discovery Market Size by Type
6.2.1 North America Phenotypic Drug Discovery Market Size by Type (2018-2023)
6.2.2 North America Phenotypic Drug Discovery Market Size by Type (2024-2029)
6.2.3 North America Phenotypic Drug Discovery Market Share by Type (2018-2029)
6.3 North America Phenotypic Drug Discovery Market Size by Application
6.3.1 North America Phenotypic Drug Discovery Market Size by Application (2018-2023)
6.3.2 North America Phenotypic Drug Discovery Market Size by Application (2024-2029)
6.3.3 North America Phenotypic Drug Discovery Market Share by Application (2018-2029)
6.4 North America Phenotypic Drug Discovery Market Size by Country
6.4.1 North America Phenotypic Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Phenotypic Drug Discovery Market Size by Country (2018-2023)
6.4.3 North America Phenotypic Drug Discovery Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Phenotypic Drug Discovery Market Size (2018-2029)
7.2 Europe Phenotypic Drug Discovery Market Size by Type
7.2.1 Europe Phenotypic Drug Discovery Market Size by Type (2018-2023)
7.2.2 Europe Phenotypic Drug Discovery Market Size by Type (2024-2029)
7.2.3 Europe Phenotypic Drug Discovery Market Share by Type (2018-2029)
7.3 Europe Phenotypic Drug Discovery Market Size by Application
7.3.1 Europe Phenotypic Drug Discovery Market Size by Application (2018-2023)
7.3.2 Europe Phenotypic Drug Discovery Market Size by Application (2024-2029)
7.3.3 Europe Phenotypic Drug Discovery Market Share by Application (2018-2029)
7.4 Europe Phenotypic Drug Discovery Market Size by Country
7.4.1 Europe Phenotypic Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Phenotypic Drug Discovery Market Size by Country (2018-2023)
7.4.3 Europe Phenotypic Drug Discovery Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Phenotypic Drug Discovery Market Size (2018-2029)
8.2 China Phenotypic Drug Discovery Market Size by Type
8.2.1 China Phenotypic Drug Discovery Market Size by Type (2018-2023)
8.2.2 China Phenotypic Drug Discovery Market Size by Type (2024-2029)
8.2.3 China Phenotypic Drug Discovery Market Share by Type (2018-2029)
8.3 China Phenotypic Drug Discovery Market Size by Application
8.3.1 China Phenotypic Drug Discovery Market Size by Application (2018-2023)
8.3.2 China Phenotypic Drug Discovery Market Size by Application (2024-2029)
8.3.3 China Phenotypic Drug Discovery Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Phenotypic Drug Discovery Market Size (2018-2029)
9.2 Asia Phenotypic Drug Discovery Market Size by Type
9.2.1 Asia Phenotypic Drug Discovery Market Size by Type (2018-2023)
9.2.2 Asia Phenotypic Drug Discovery Market Size by Type (2024-2029)
9.2.3 Asia Phenotypic Drug Discovery Market Share by Type (2018-2029)
9.3 Asia Phenotypic Drug Discovery Market Size by Application
9.3.1 Asia Phenotypic Drug Discovery Market Size by Application (2018-2023)
9.3.2 Asia Phenotypic Drug Discovery Market Size by Application (2024-2029)
9.3.3 Asia Phenotypic Drug Discovery Market Share by Application (2018-2029)
9.4 Asia Phenotypic Drug Discovery Market Size by Region
9.4.1 Asia Phenotypic Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Phenotypic Drug Discovery Market Size by Region (2018-2023)
9.4.3 Asia Phenotypic Drug Discovery Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Type
10.2.1 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Application
10.3.1 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Country
10.4.1 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Eurofins Discovery
11.1.1 Eurofins Discovery Company Details
11.1.2 Eurofins Discovery Business Overview
11.1.3 Eurofins Discovery Phenotypic Drug Discovery Introduction
11.1.4 Eurofins Discovery Revenue in Phenotypic Drug Discovery Business (2018-2023)
11.1.5 Eurofins Discovery Recent Developments
11.2 Sygnature Discovery
11.2.1 Sygnature Discovery Company Details
11.2.2 Sygnature Discovery Business Overview
11.2.3 Sygnature Discovery Phenotypic Drug Discovery Introduction
11.2.4 Sygnature Discovery Revenue in Phenotypic Drug Discovery Business (2018-2023)
11.2.5 Sygnature Discovery Recent Developments
11.3 PsychoGenics
11.3.1 PsychoGenics Company Details
11.3.2 PsychoGenics Business Overview
11.3.3 PsychoGenics Phenotypic Drug Discovery Introduction
11.3.4 PsychoGenics Revenue in Phenotypic Drug Discovery Business (2018-2023)
11.3.5 PsychoGenics Recent Developments
11.4 siTOOLs Biotech
11.4.1 siTOOLs Biotech Company Details
11.4.2 siTOOLs Biotech Business Overview
11.4.3 siTOOLs Biotech Phenotypic Drug Discovery Introduction
11.4.4 siTOOLs Biotech Revenue in Phenotypic Drug Discovery Business (2018-2023)
11.4.5 siTOOLs Biotech Recent Developments
11.5 PhoreMost
11.5.1 PhoreMost Company Details
11.5.2 PhoreMost Business Overview
11.5.3 PhoreMost Phenotypic Drug Discovery Introduction
11.5.4 PhoreMost Revenue in Phenotypic Drug Discovery Business (2018-2023)
11.5.5 PhoreMost Recent Developments
11.6 Charles River
11.6.1 Charles River Company Details
11.6.2 Charles River Business Overview
11.6.3 Charles River Phenotypic Drug Discovery Introduction
11.6.4 Charles River Revenue in Phenotypic Drug Discovery Business (2018-2023)
11.6.5 Charles River Recent Developments
11.7 MaxWell
11.7.1 MaxWell Company Details
11.7.2 MaxWell Business Overview
11.7.3 MaxWell Phenotypic Drug Discovery Introduction
11.7.4 MaxWell Revenue in Phenotypic Drug Discovery Business (2018-2023)
11.7.5 MaxWell Recent Developments
11.8 Arctoris
11.8.1 Arctoris Company Details
11.8.2 Arctoris Business Overview
11.8.3 Arctoris Phenotypic Drug Discovery Introduction
11.8.4 Arctoris Revenue in Phenotypic Drug Discovery Business (2018-2023)
11.8.5 Arctoris Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phenotypic Drug Discovery Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Platform
1.2.3 Service
1.3 Market by Application
1.3.1 Global Phenotypic Drug Discovery Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Viral Infection
1.3.4 Genetic Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Phenotypic Drug Discovery Market Perspective (2018-2029)
2.2 Global Phenotypic Drug Discovery Growth Trends by Region
2.2.1 Phenotypic Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Phenotypic Drug Discovery Historic Market Size by Region (2018-2023)
2.2.3 Phenotypic Drug Discovery Forecasted Market Size by Region (2024-2029)
2.3 Phenotypic Drug Discovery Market Dynamics
2.3.1 Phenotypic Drug Discovery Industry Trends
2.3.2 Phenotypic Drug Discovery Market Drivers
2.3.3 Phenotypic Drug Discovery Market Challenges
2.3.4 Phenotypic Drug Discovery Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Phenotypic Drug Discovery by Players
3.1.1 Global Phenotypic Drug Discovery Revenue by Players (2018-2023)
3.1.2 Global Phenotypic Drug Discovery Revenue Market Share by Players (2018-2023)
3.2 Global Phenotypic Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Phenotypic Drug Discovery, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Phenotypic Drug Discovery Market Concentration Ratio
3.4.1 Global Phenotypic Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phenotypic Drug Discovery Revenue in 2022
3.5 Global Key Players of Phenotypic Drug Discovery Head office and Area Served
3.6 Global Key Players of Phenotypic Drug Discovery, Product and Application
3.7 Global Key Players of Phenotypic Drug Discovery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 PHENOTYPIC DRUG DISCOVERY BREAKDOWN DATA BY TYPE
4.1 Global Phenotypic Drug Discovery Historic Market Size by Type (2018-2023)
4.2 Global Phenotypic Drug Discovery Forecasted Market Size by Type (2024-2029)
5 PHENOTYPIC DRUG DISCOVERY BREAKDOWN DATA BY APPLICATION
5.1 Global Phenotypic Drug Discovery Historic Market Size by Application (2018-2023)
5.2 Global Phenotypic Drug Discovery Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Phenotypic Drug Discovery Market Size (2018-2029)
6.2 North America Phenotypic Drug Discovery Market Size by Type
6.2.1 North America Phenotypic Drug Discovery Market Size by Type (2018-2023)
6.2.2 North America Phenotypic Drug Discovery Market Size by Type (2024-2029)
6.2.3 North America Phenotypic Drug Discovery Market Share by Type (2018-2029)
6.3 North America Phenotypic Drug Discovery Market Size by Application
6.3.1 North America Phenotypic Drug Discovery Market Size by Application (2018-2023)
6.3.2 North America Phenotypic Drug Discovery Market Size by Application (2024-2029)
6.3.3 North America Phenotypic Drug Discovery Market Share by Application (2018-2029)
6.4 North America Phenotypic Drug Discovery Market Size by Country
6.4.1 North America Phenotypic Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Phenotypic Drug Discovery Market Size by Country (2018-2023)
6.4.3 North America Phenotypic Drug Discovery Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Phenotypic Drug Discovery Market Size (2018-2029)
7.2 Europe Phenotypic Drug Discovery Market Size by Type
7.2.1 Europe Phenotypic Drug Discovery Market Size by Type (2018-2023)
7.2.2 Europe Phenotypic Drug Discovery Market Size by Type (2024-2029)
7.2.3 Europe Phenotypic Drug Discovery Market Share by Type (2018-2029)
7.3 Europe Phenotypic Drug Discovery Market Size by Application
7.3.1 Europe Phenotypic Drug Discovery Market Size by Application (2018-2023)
7.3.2 Europe Phenotypic Drug Discovery Market Size by Application (2024-2029)
7.3.3 Europe Phenotypic Drug Discovery Market Share by Application (2018-2029)
7.4 Europe Phenotypic Drug Discovery Market Size by Country
7.4.1 Europe Phenotypic Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Phenotypic Drug Discovery Market Size by Country (2018-2023)
7.4.3 Europe Phenotypic Drug Discovery Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Phenotypic Drug Discovery Market Size (2018-2029)
8.2 China Phenotypic Drug Discovery Market Size by Type
8.2.1 China Phenotypic Drug Discovery Market Size by Type (2018-2023)
8.2.2 China Phenotypic Drug Discovery Market Size by Type (2024-2029)
8.2.3 China Phenotypic Drug Discovery Market Share by Type (2018-2029)
8.3 China Phenotypic Drug Discovery Market Size by Application
8.3.1 China Phenotypic Drug Discovery Market Size by Application (2018-2023)
8.3.2 China Phenotypic Drug Discovery Market Size by Application (2024-2029)
8.3.3 China Phenotypic Drug Discovery Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Phenotypic Drug Discovery Market Size (2018-2029)
9.2 Asia Phenotypic Drug Discovery Market Size by Type
9.2.1 Asia Phenotypic Drug Discovery Market Size by Type (2018-2023)
9.2.2 Asia Phenotypic Drug Discovery Market Size by Type (2024-2029)
9.2.3 Asia Phenotypic Drug Discovery Market Share by Type (2018-2029)
9.3 Asia Phenotypic Drug Discovery Market Size by Application
9.3.1 Asia Phenotypic Drug Discovery Market Size by Application (2018-2023)
9.3.2 Asia Phenotypic Drug Discovery Market Size by Application (2024-2029)
9.3.3 Asia Phenotypic Drug Discovery Market Share by Application (2018-2029)
9.4 Asia Phenotypic Drug Discovery Market Size by Region
9.4.1 Asia Phenotypic Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Phenotypic Drug Discovery Market Size by Region (2018-2023)
9.4.3 Asia Phenotypic Drug Discovery Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Type
10.2.1 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Application
10.3.1 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Country
10.4.1 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Eurofins Discovery
11.1.1 Eurofins Discovery Company Details
11.1.2 Eurofins Discovery Business Overview
11.1.3 Eurofins Discovery Phenotypic Drug Discovery Introduction
11.1.4 Eurofins Discovery Revenue in Phenotypic Drug Discovery Business (2018-2023)
11.1.5 Eurofins Discovery Recent Developments
11.2 Sygnature Discovery
11.2.1 Sygnature Discovery Company Details
11.2.2 Sygnature Discovery Business Overview
11.2.3 Sygnature Discovery Phenotypic Drug Discovery Introduction
11.2.4 Sygnature Discovery Revenue in Phenotypic Drug Discovery Business (2018-2023)
11.2.5 Sygnature Discovery Recent Developments
11.3 PsychoGenics
11.3.1 PsychoGenics Company Details
11.3.2 PsychoGenics Business Overview
11.3.3 PsychoGenics Phenotypic Drug Discovery Introduction
11.3.4 PsychoGenics Revenue in Phenotypic Drug Discovery Business (2018-2023)
11.3.5 PsychoGenics Recent Developments
11.4 siTOOLs Biotech
11.4.1 siTOOLs Biotech Company Details
11.4.2 siTOOLs Biotech Business Overview
11.4.3 siTOOLs Biotech Phenotypic Drug Discovery Introduction
11.4.4 siTOOLs Biotech Revenue in Phenotypic Drug Discovery Business (2018-2023)
11.4.5 siTOOLs Biotech Recent Developments
11.5 PhoreMost
11.5.1 PhoreMost Company Details
11.5.2 PhoreMost Business Overview
11.5.3 PhoreMost Phenotypic Drug Discovery Introduction
11.5.4 PhoreMost Revenue in Phenotypic Drug Discovery Business (2018-2023)
11.5.5 PhoreMost Recent Developments
11.6 Charles River
11.6.1 Charles River Company Details
11.6.2 Charles River Business Overview
11.6.3 Charles River Phenotypic Drug Discovery Introduction
11.6.4 Charles River Revenue in Phenotypic Drug Discovery Business (2018-2023)
11.6.5 Charles River Recent Developments
11.7 MaxWell
11.7.1 MaxWell Company Details
11.7.2 MaxWell Business Overview
11.7.3 MaxWell Phenotypic Drug Discovery Introduction
11.7.4 MaxWell Revenue in Phenotypic Drug Discovery Business (2018-2023)
11.7.5 MaxWell Recent Developments
11.8 Arctoris
11.8.1 Arctoris Company Details
11.8.2 Arctoris Business Overview
11.8.3 Arctoris Phenotypic Drug Discovery Introduction
11.8.4 Arctoris Revenue in Phenotypic Drug Discovery Business (2018-2023)
11.8.5 Arctoris Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Phenotypic Drug Discovery Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Platform
Table 3. Key Players of Service
Table 4. Global Phenotypic Drug Discovery Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Phenotypic Drug Discovery Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Phenotypic Drug Discovery Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Phenotypic Drug Discovery Market Share by Region (2018-2023)
Table 8. Global Phenotypic Drug Discovery Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Phenotypic Drug Discovery Market Share by Region (2024-2029)
Table 10. Phenotypic Drug Discovery Market Trends
Table 11. Phenotypic Drug Discovery Market Drivers
Table 12. Phenotypic Drug Discovery Market Challenges
Table 13. Phenotypic Drug Discovery Market Restraints
Table 14. Global Phenotypic Drug Discovery Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Phenotypic Drug Discovery Revenue Share by Players (2018-2023)
Table 16. Global Top Phenotypic Drug Discovery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenotypic Drug Discovery as of 2022)
Table 17. Global Phenotypic Drug Discovery Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Phenotypic Drug Discovery Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Phenotypic Drug Discovery, Headquarters and Area Served
Table 20. Global Key Players of Phenotypic Drug Discovery, Product and Application
Table 21. Global Key Players of Phenotypic Drug Discovery, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Phenotypic Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Phenotypic Drug Discovery Revenue Market Share by Type (2018-2023)
Table 25. Global Phenotypic Drug Discovery Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Phenotypic Drug Discovery Revenue Market Share by Type (2024-2029)
Table 27. Global Phenotypic Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Phenotypic Drug Discovery Revenue Share by Application (2018-2023)
Table 29. Global Phenotypic Drug Discovery Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Phenotypic Drug Discovery Revenue Share by Application (2024-2029)
Table 31. North America Phenotypic Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Phenotypic Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Phenotypic Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Phenotypic Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Phenotypic Drug Discovery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Phenotypic Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Phenotypic Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Phenotypic Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Phenotypic Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Phenotypic Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Phenotypic Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Phenotypic Drug Discovery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Phenotypic Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Phenotypic Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Phenotypic Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Phenotypic Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Phenotypic Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Phenotypic Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Phenotypic Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Phenotypic Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Phenotypic Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Phenotypic Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Phenotypic Drug Discovery Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Phenotypic Drug Discovery Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Phenotypic Drug Discovery Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Phenotypic Drug Discovery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 63. Eurofins Discovery Company Details
Table 64. Eurofins Discovery Business Overview
Table 65. Eurofins Discovery Phenotypic Drug Discovery Product
Table 66. Eurofins Discovery Revenue in Phenotypic Drug Discovery Business (2018-2023) & (US$ Million)
Table 67. Eurofins Discovery Recent Developments
Table 68. Sygnature Discovery Company Details
Table 69. Sygnature Discovery Business Overview
Table 70. Sygnature Discovery Phenotypic Drug Discovery Product
Table 71. Sygnature Discovery Revenue in Phenotypic Drug Discovery Business (2018-2023) & (US$ Million)
Table 72. Sygnature Discovery Recent Developments
Table 73. PsychoGenics Company Details
Table 74. PsychoGenics Business Overview
Table 75. PsychoGenics Phenotypic Drug Discovery Product
Table 76. PsychoGenics Revenue in Phenotypic Drug Discovery Business (2018-2023) & (US$ Million)
Table 77. PsychoGenics Recent Developments
Table 78. siTOOLs Biotech Company Details
Table 79. siTOOLs Biotech Business Overview
Table 80. siTOOLs Biotech Phenotypic Drug Discovery Product
Table 81. siTOOLs Biotech Revenue in Phenotypic Drug Discovery Business (2018-2023) & (US$ Million)
Table 82. siTOOLs Biotech Recent Developments
Table 83. PhoreMost Company Details
Table 84. PhoreMost Business Overview
Table 85. PhoreMost Phenotypic Drug Discovery Product
Table 86. PhoreMost Revenue in Phenotypic Drug Discovery Business (2018-2023) & (US$ Million)
Table 87. PhoreMost Recent Developments
Table 88. Charles River Company Details
Table 89. Charles River Business Overview
Table 90. Charles River Phenotypic Drug Discovery Product
Table 91. Charles River Revenue in Phenotypic Drug Discovery Business (2018-2023) & (US$ Million)
Table 92. Charles River Recent Developments
Table 93. MaxWell Company Details
Table 94. MaxWell Business Overview
Table 95. MaxWell Phenotypic Drug Discovery Product
Table 96. MaxWell Revenue in Phenotypic Drug Discovery Business (2018-2023) & (US$ Million)
Table 97. MaxWell Recent Developments
Table 98. Arctoris Company Details
Table 99. Arctoris Business Overview
Table 100. Arctoris Phenotypic Drug Discovery Product
Table 101. Arctoris Revenue in Phenotypic Drug Discovery Business (2018-2023) & (US$ Million)
Table 102. Arctoris Recent Developments
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 1. Global Phenotypic Drug Discovery Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Platform
Table 3. Key Players of Service
Table 4. Global Phenotypic Drug Discovery Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Phenotypic Drug Discovery Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Phenotypic Drug Discovery Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Phenotypic Drug Discovery Market Share by Region (2018-2023)
Table 8. Global Phenotypic Drug Discovery Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Phenotypic Drug Discovery Market Share by Region (2024-2029)
Table 10. Phenotypic Drug Discovery Market Trends
Table 11. Phenotypic Drug Discovery Market Drivers
Table 12. Phenotypic Drug Discovery Market Challenges
Table 13. Phenotypic Drug Discovery Market Restraints
Table 14. Global Phenotypic Drug Discovery Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Phenotypic Drug Discovery Revenue Share by Players (2018-2023)
Table 16. Global Top Phenotypic Drug Discovery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenotypic Drug Discovery as of 2022)
Table 17. Global Phenotypic Drug Discovery Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Phenotypic Drug Discovery Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Phenotypic Drug Discovery, Headquarters and Area Served
Table 20. Global Key Players of Phenotypic Drug Discovery, Product and Application
Table 21. Global Key Players of Phenotypic Drug Discovery, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Phenotypic Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Phenotypic Drug Discovery Revenue Market Share by Type (2018-2023)
Table 25. Global Phenotypic Drug Discovery Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Phenotypic Drug Discovery Revenue Market Share by Type (2024-2029)
Table 27. Global Phenotypic Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Phenotypic Drug Discovery Revenue Share by Application (2018-2023)
Table 29. Global Phenotypic Drug Discovery Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Phenotypic Drug Discovery Revenue Share by Application (2024-2029)
Table 31. North America Phenotypic Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Phenotypic Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Phenotypic Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Phenotypic Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Phenotypic Drug Discovery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Phenotypic Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Phenotypic Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Phenotypic Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Phenotypic Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Phenotypic Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Phenotypic Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Phenotypic Drug Discovery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Phenotypic Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Phenotypic Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Phenotypic Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Phenotypic Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Phenotypic Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Phenotypic Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Phenotypic Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Phenotypic Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Phenotypic Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Phenotypic Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Phenotypic Drug Discovery Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Phenotypic Drug Discovery Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Phenotypic Drug Discovery Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Phenotypic Drug Discovery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 63. Eurofins Discovery Company Details
Table 64. Eurofins Discovery Business Overview
Table 65. Eurofins Discovery Phenotypic Drug Discovery Product
Table 66. Eurofins Discovery Revenue in Phenotypic Drug Discovery Business (2018-2023) & (US$ Million)
Table 67. Eurofins Discovery Recent Developments
Table 68. Sygnature Discovery Company Details
Table 69. Sygnature Discovery Business Overview
Table 70. Sygnature Discovery Phenotypic Drug Discovery Product
Table 71. Sygnature Discovery Revenue in Phenotypic Drug Discovery Business (2018-2023) & (US$ Million)
Table 72. Sygnature Discovery Recent Developments
Table 73. PsychoGenics Company Details
Table 74. PsychoGenics Business Overview
Table 75. PsychoGenics Phenotypic Drug Discovery Product
Table 76. PsychoGenics Revenue in Phenotypic Drug Discovery Business (2018-2023) & (US$ Million)
Table 77. PsychoGenics Recent Developments
Table 78. siTOOLs Biotech Company Details
Table 79. siTOOLs Biotech Business Overview
Table 80. siTOOLs Biotech Phenotypic Drug Discovery Product
Table 81. siTOOLs Biotech Revenue in Phenotypic Drug Discovery Business (2018-2023) & (US$ Million)
Table 82. siTOOLs Biotech Recent Developments
Table 83. PhoreMost Company Details
Table 84. PhoreMost Business Overview
Table 85. PhoreMost Phenotypic Drug Discovery Product
Table 86. PhoreMost Revenue in Phenotypic Drug Discovery Business (2018-2023) & (US$ Million)
Table 87. PhoreMost Recent Developments
Table 88. Charles River Company Details
Table 89. Charles River Business Overview
Table 90. Charles River Phenotypic Drug Discovery Product
Table 91. Charles River Revenue in Phenotypic Drug Discovery Business (2018-2023) & (US$ Million)
Table 92. Charles River Recent Developments
Table 93. MaxWell Company Details
Table 94. MaxWell Business Overview
Table 95. MaxWell Phenotypic Drug Discovery Product
Table 96. MaxWell Revenue in Phenotypic Drug Discovery Business (2018-2023) & (US$ Million)
Table 97. MaxWell Recent Developments
Table 98. Arctoris Company Details
Table 99. Arctoris Business Overview
Table 100. Arctoris Phenotypic Drug Discovery Product
Table 101. Arctoris Revenue in Phenotypic Drug Discovery Business (2018-2023) & (US$ Million)
Table 102. Arctoris Recent Developments
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Phenotypic Drug Discovery Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Phenotypic Drug Discovery Market Share by Type: 2022 VS 2029
Figure 3. Platform Features
Figure 4. Service Features
Figure 5. Global Phenotypic Drug Discovery Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Phenotypic Drug Discovery Market Share by Application: 2022 VS 2029
Figure 7. Cancer Case Studies
Figure 8. Viral Infection Case Studies
Figure 9. Genetic Disease Case Studies
Figure 10. Others Case Studies
Figure 11. Phenotypic Drug Discovery Report Years Considered
Figure 12. Global Phenotypic Drug Discovery Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Phenotypic Drug Discovery Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Phenotypic Drug Discovery Market Share by Region: 2022 VS 2029
Figure 15. Global Phenotypic Drug Discovery Market Share by Players in 2022
Figure 16. Global Top Phenotypic Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenotypic Drug Discovery as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Phenotypic Drug Discovery Revenue in 2022
Figure 18. North America Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Phenotypic Drug Discovery Market Share by Type (2018-2029)
Figure 20. North America Phenotypic Drug Discovery Market Share by Application (2018-2029)
Figure 21. North America Phenotypic Drug Discovery Market Share by Country (2018-2029)
Figure 22. United States Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Phenotypic Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Phenotypic Drug Discovery Market Share by Type (2018-2029)
Figure 26. Europe Phenotypic Drug Discovery Market Share by Application (2018-2029)
Figure 27. Europe Phenotypic Drug Discovery Market Share by Country (2018-2029)
Figure 28. Germany Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Phenotypic Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Phenotypic Drug Discovery Market Share by Type (2018-2029)
Figure 36. China Phenotypic Drug Discovery Market Share by Application (2018-2029)
Figure 37. Asia Phenotypic Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Phenotypic Drug Discovery Market Share by Type (2018-2029)
Figure 39. Asia Phenotypic Drug Discovery Market Share by Application (2018-2029)
Figure 40. Asia Phenotypic Drug Discovery Market Share by Region (2018-2029)
Figure 41. Japan Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Share by Country (2018-2029)
Figure 51. Brazil Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Eurofins Discovery Revenue Growth Rate in Phenotypic Drug Discovery Business (2018-2023)
Figure 58. Sygnature Discovery Revenue Growth Rate in Phenotypic Drug Discovery Business (2018-2023)
Figure 59. PsychoGenics Revenue Growth Rate in Phenotypic Drug Discovery Business (2018-2023)
Figure 60. siTOOLs Biotech Revenue Growth Rate in Phenotypic Drug Discovery Business (2018-2023)
Figure 61. PhoreMost Revenue Growth Rate in Phenotypic Drug Discovery Business (2018-2023)
Figure 62. Charles River Revenue Growth Rate in Phenotypic Drug Discovery Business (2018-2023)
Figure 63. MaxWell Revenue Growth Rate in Phenotypic Drug Discovery Business (2018-2023)
Figure 64. Arctoris Revenue Growth Rate in Phenotypic Drug Discovery Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Figure 1. Global Phenotypic Drug Discovery Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Phenotypic Drug Discovery Market Share by Type: 2022 VS 2029
Figure 3. Platform Features
Figure 4. Service Features
Figure 5. Global Phenotypic Drug Discovery Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Phenotypic Drug Discovery Market Share by Application: 2022 VS 2029
Figure 7. Cancer Case Studies
Figure 8. Viral Infection Case Studies
Figure 9. Genetic Disease Case Studies
Figure 10. Others Case Studies
Figure 11. Phenotypic Drug Discovery Report Years Considered
Figure 12. Global Phenotypic Drug Discovery Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Phenotypic Drug Discovery Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Phenotypic Drug Discovery Market Share by Region: 2022 VS 2029
Figure 15. Global Phenotypic Drug Discovery Market Share by Players in 2022
Figure 16. Global Top Phenotypic Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenotypic Drug Discovery as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Phenotypic Drug Discovery Revenue in 2022
Figure 18. North America Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Phenotypic Drug Discovery Market Share by Type (2018-2029)
Figure 20. North America Phenotypic Drug Discovery Market Share by Application (2018-2029)
Figure 21. North America Phenotypic Drug Discovery Market Share by Country (2018-2029)
Figure 22. United States Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Phenotypic Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Phenotypic Drug Discovery Market Share by Type (2018-2029)
Figure 26. Europe Phenotypic Drug Discovery Market Share by Application (2018-2029)
Figure 27. Europe Phenotypic Drug Discovery Market Share by Country (2018-2029)
Figure 28. Germany Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Phenotypic Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Phenotypic Drug Discovery Market Share by Type (2018-2029)
Figure 36. China Phenotypic Drug Discovery Market Share by Application (2018-2029)
Figure 37. Asia Phenotypic Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Phenotypic Drug Discovery Market Share by Type (2018-2029)
Figure 39. Asia Phenotypic Drug Discovery Market Share by Application (2018-2029)
Figure 40. Asia Phenotypic Drug Discovery Market Share by Region (2018-2029)
Figure 41. Japan Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Phenotypic Drug Discovery Market Share by Country (2018-2029)
Figure 51. Brazil Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Phenotypic Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Eurofins Discovery Revenue Growth Rate in Phenotypic Drug Discovery Business (2018-2023)
Figure 58. Sygnature Discovery Revenue Growth Rate in Phenotypic Drug Discovery Business (2018-2023)
Figure 59. PsychoGenics Revenue Growth Rate in Phenotypic Drug Discovery Business (2018-2023)
Figure 60. siTOOLs Biotech Revenue Growth Rate in Phenotypic Drug Discovery Business (2018-2023)
Figure 61. PhoreMost Revenue Growth Rate in Phenotypic Drug Discovery Business (2018-2023)
Figure 62. Charles River Revenue Growth Rate in Phenotypic Drug Discovery Business (2018-2023)
Figure 63. MaxWell Revenue Growth Rate in Phenotypic Drug Discovery Business (2018-2023)
Figure 64. Arctoris Revenue Growth Rate in Phenotypic Drug Discovery Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
